Health
COVID vaccines focus on the spike protein – but here’s another target – The Conversation UK
New research shows why the N protein might be a good target.
The latest results from the phase 3 COVID-19 vaccines trials have been very positive. These have shown that vaccinating people with the gene for SARS-CoV-2 spike protein can induce excellent protective immunity.
The spike protein is the focus of most COVID-19 vaccines as it is the part of the virus that enables it to enter our cells. Virus replication only happens inside cells, so blocking entry prevents more virus being made. If a person has antibodies that can recognise the spike protein, this…
-
Noosa News22 hours agoBrisbane doctor jailed for trafficking ‘breathtaking amount’ of drugs
-
General17 hours ago‘We are here for you’: PM to bring help to flood zones
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General12 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains